HIGHLIGHTS
- who: Sneha Bansode and colleagues from the Pune, India have published the article: A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine, in the Journal: Vaccines 2023, 515 of 28/Dec/2022
- what: This study reports the comprehensive evaluation of SOF, DCV, and LDP on RdRp of SARS-CoV-2 by computational approaches such as interaction analysis and molecular dynamic simulations. Although DCV has been shown to have a strong binding affinity molecular docking analysis, the study has validated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.